Malignant B Cells at the Helm in Follicular Lymphoma

被引：8
作者：
Ansell, Stephen M. [1 ]
机构：
[1] Mayo Clin, Rochester, MN 55905 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 21期
关键词：
NON-HODGKIN-LYMPHOMA; REGULATORY T-CELLS; EXPRESSION;
D O I：
10.1200/JCO.2013.49.2165
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2641 / 2642
页数：2
相关论文
共 13 条
  • [1] Programmed Death Ligand 1 Is Expressed by Non-Hodgkin Lymphomas and Inhibits the Activity of Tumor-Associated T Cells
    Andorsky, David J.
    Yamada, Reiko E.
    Said, Jonathan
    Pinkus, Geraldine S.
    Betting, David J.
    Timmerman, John M.
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (13) : 4232 - 4244
  • [2] Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients
    Ansell, Stephen M.
    Maurer, Matthew J.
    Ziesmer, Steven C.
    Slager, Susan L.
    Habermann, Thomas M.
    Link, Brian K.
    Witzig, Thomas E.
    Macon, William R.
    Dogan, Ahmet
    Cerhan, James R.
    Novak, Anne J.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (09) : 865 - 869
  • [3] Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions
    Curran, Kevin J.
    Pegram, Hollie J.
    Brentjens, Renier J.
    [J]. JOURNAL OF GENE MEDICINE, 2012, 14 (06) : 405 - 415
  • [4] Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
    Dave, SS
    Wright, G
    Tan, B
    Rosenwald, A
    Gascoyne, RD
    Chan, WC
    Fisher, RI
    Braziel, RM
    Rimsza, LM
    Grogan, TM
    Miller, TP
    LeBlanc, M
    Greiner, TC
    Weisenburger, DD
    Lynch, JC
    Vose, J
    Armitage, JO
    Smeland, EB
    Kvaloy, S
    Holte, H
    Delabie, J
    Connors, JM
    Lansdorp, PM
    Ouyang, Q
    Lister, TA
    Davies, AJ
    Norton, AJ
    Muller-Hermelink, HK
    Ott, G
    Campo, E
    Montserrat, E
    Wilson, WH
    Jaffe, ES
    Simon, R
    Yang, LM
    Powell, J
    Zhao, H
    Goldschmidt, N
    Chiorazzi, M
    Staudt, LM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (21) : 2159 - 2169
  • [5] How do CARs work? Early insights from recent clinical studies targeting CD19
    Davila, Marco L.
    Brentjens, Renier
    Wang, Xiuyan
    Riviere, Isabelle
    Sadelain, Michel
    [J]. ONCOIMMUNOLOGY, 2012, 1 (09): : 1577 - 1583
  • [6] Follicular Lymphoma Cells Induce Changes in T-Cell Gene Expression and Function: Potential Impact on Survival and Risk of Transformation
    Kiaii, Shahryar
    Clear, Andrew J.
    Ramsay, Alan G.
    Davies, Derek
    Sangaralingam, Ajanthah
    Lee, Abigail
    Calaminici, Maria
    Neuberg, Donna S.
    Gribben, John G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (21) : 2654 - +
  • [7] Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia
    Porter, David L.
    Levine, Bruce L.
    Kalos, Michael
    Bagg, Adam
    June, Carl H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (08) : 725 - 733
  • [8] B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders
    Wilcox, Ryan A.
    Feldman, Andrew L.
    Wada, David A.
    Yang, Zhi-Zhang
    Comfere, Nneka I.
    Dong, Haidong
    Kwon, Eugene D.
    Novak, Anne J.
    Markovic, Svetomir N.
    Pittelkow, Mark R.
    Witzig, Thomas E.
    Ansell, Stephen M.
    [J]. BLOOD, 2009, 114 (10) : 2149 - 2158
  • [9] CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intraturnoral CD4+CD25- T cells
    Yang, Zhi-Zhang
    Novak, Anne J.
    Ziesmer, Steven C.
    Witzig, Thomas E.
    Ansell, Stephen M.
    [J]. BLOOD, 2007, 110 (07) : 2537 - 2544
  • [10] Attenuation of CD8+ T-cell function by CD4+CD25+ regulatory T cells in B-cell non-Hodgkin's lymphoma
    Yang, Zhi-Zhang
    Novak, Anne J.
    Ziesmer, Steven C.
    Witzig, Thomas E.
    Ansell, Stephen M.
    [J]. CANCER RESEARCH, 2006, 66 (20) : 10145 - 10152
12